Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Download in electronic PDF format for $65
Abstract: Pharmacists involved in compounding must consider a number of factors when determining the actual quantity of an active ingredient to use for a compounded prescription. Many drug substances do not consist of 100% drug or chemical, and adjustments must be made to obtain the required amount of active drug (active pharmaceutical ingredient). This article covers the topic of compounding with “potency-designated” drugs.
Related Keywords:
Loyd V. Allen Jr., PhD, RPh, bulk substance potency, biologic agents, biological agents, active pharmaceutical ingredients, drug potency designations, drug activity
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 56-61
|
Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
|
Jan/Feb 2003
Pg. 10-15
View Sample |
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
|
Sep/Oct 2021
Pg. 358-362
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents
Allen Loyd V Jr, McKenzie Robert, Ainsworth Ron, Kastango Eric S, Kaestner Rick, Rebelo Andre, Burnside Paul, Schultz Gerald
|
Jul/Aug 2010
Pg. 284-300
|
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
|
Jul/Aug 2015
Pg. 303-305
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
